Kaiser wants teens for COVID-19 vaccine trial

Phase 3 trials for the Pfizer vaccine show it was 95% effective in adults, now the company wants to know how it will work in teens. Kaiser Permanente is enrolling 16 and 17-year-olds to participate in clinical trials for the vaccine.

Top Videos

Most Watched

KTVU Vault

Wild Rides